XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 29, 2023
Sep. 30, 2022
Cash flow from operating activities:    
Net income (loss) $ (686) $ 5,382
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization expense 2,750 2,051
Equity-based compensation expense 1,077 1,869
Deferred income taxes (1,730) (138)
Deferred compensation benefits 555 (152)
Loss on the sale of property and equipment 4  
Changes in assets and liabilities that provide (use) cash, excluding the effects of acquisitions:    
Accounts receivable 6,247 11,614
Prepaid and other current assets (923) (395)
Other long-term assets (213) (41)
Cash surrender value of life insurance (55) 525
Accounts payable (5,089) (10,159)
Accrued compensation (394) (63)
Income taxes payable / receivable (378) 1,189
Advance billings on contracts (1,026) 670
Other current liabilities 3,536 151
Other long-term liabilities (893) 6
Net cash provided by operating activities 2,782 12,509
Cash flow from investing activities:    
Cash paid for acquisitions, net of cash acquired 82 (16,568)
Additions to property and equipment (1,288) (479)
Additions to capitalized software (1,207) (285)
Proceeds from sale of property & equipment 4 9
Premiums paid for life insurance (647) (594)
Net cash used in investing activities (3,056) (17,917)
Cash flow from financing activities:    
Proceeds from long-term debt 20,653  
Payments on long-term debt (20,653)  
Payment of contingent consideration (913)  
Proceeds from stock option plan exercises 174 215
Taxes remitted for shares withheld from equity-based compensation transactions (629) (1,230)
Proceeds from Employee Stock Purchase Plan 108 131
Change in cash overdraft, net 474  
Net cash used in financing activities (786) (884)
Effect of exchange rates on cash and cash equivalents (11) (2,539)
Net decrease in cash and cash equivalents (1,071) (8,831)
Cash and cash equivalents at beginning of year 25,140 35,584
Cash and cash equivalents at end of quarter $ 24,069 26,753
Supplemental disclosure of non-cash transactions    
Acquisition share issuance   1,178
Acquisition stock option issuance   $ 391